The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

13 Apr 2021 07:00

RNS Number : 2087V
Electrocomponents PLC
13 April 2021
 

Electrocomponents plc today issues a trading update for the year ended 31 March 2021, ahead of publishing full-year results on 25 May 2021

 

LINDSLEY RUTH, CHIEF EXECUTIVE OFFICER, COMMENTED: "We are very pleased with another strong performance in the fourth quarter. The business demonstrated its resilience and agility once more, rising to the combined challenges of lockdown, Brexit and extreme weather conditions in Texas with trading not missing a beat; Group performance continued at a similar rate to the third quarter until mid-March. The last two weeks of the period saw a material improvement in revenue growth against weaker comparatives when most of EMEA entered the first COVID-19 lockdowns. We expect profit for the year ended 31 March 2021 to be around the top end of the consensus range(1).

 

The response of our people to the challenges faced this year has been exceptional and our outperformance continues to demonstrate the strength of our differentiated proposition which is resonating with both our customers and suppliers, delivering market share gains and deeper customer relationships. However, we remain highly mindful of the external pressures such as continuing freight inflation, COVID-19 uncertainties, translation headwind from sterling's strength, Brexit and ongoing unwinding of weak comparatives, but also excited about the trading opportunities we see. Looking forward to the year ahead, we are well positioned to deliver ongoing growth in line with expectations through continued organic and strategic investment, whilst operational efficiencies will drive margins as we continue on our Destination 2025 journey."

 

Like -for-like revenue growth(2)

Region

Q3 to Dec 2020

Q4 to Mar 2021

 

Year to Mar 2021

EMEA

8%

12%

 

1%

Americas

9%

13%

 

1%

Asia Pacific

10%

12%

 

5%

Group

8%

12%

 

1%

 

· Strong revenue performance across Q4 with continued market share gains

o Group Q4 like-for-like revenue growth of 12%, of which c. 4% benefit from weaker COVID-19 comparatives

o Within EMEA, UK momentum improved from end of January, resulting in high single digit growth in Q4

o Our other EMEA markets grew double digits due to tougher COVID-19 impacts in March 2020

o Strong performance in the Americas, overcoming the negative impact from extreme weather in February

o Growth in Asia Pacific underpinned by strong double-digit increase in Greater China

o RS PRO revenue grew 18% like-for-like (c. 5% benefit from COVID-19 comparatives); full year up 10%

o Digital like-for-like revenue grew 12% (c. 4% benefit from COVID-19 comparatives); web revenue rose 14%

 

· Full year 2020/21 profit expected to be around the top end of the consensus range(1) following stronger end of year revenue growth

o Second half gross margin likely to be lower than first half due to continuing cost pressures in freight, a regional mix effect and inventory provisions (including c. 100bp year-on-year hit from deflated PPE products)

o Operating costs affected by ongoing COVID-19 related charges in freight and labour and a higher cost to serve post Brexit, accounting for additional c. £9 million in H2

o RISE programme on track, delivering c. £7 million of operational savings this year

 

· Cost pressures in 2021/22 include ongoing freight inflation, COVID-19 uncertainties, Brexit and translation impact of stronger sterling(3)

 

· Continued focus on cash generation to support organic and inorganic strategic growth

o Addition of John Liscombe Limited in February, the third acquisition this financial year

o All acquisitions performing in line with expectations, with future cross-selling opportunities on track

o Pipeline of strategic inorganic opportunities is strong, and we retain a rigorous focus on value creation

 

LEI: 549300KVXDURRKVWR37

 

Enquiries:

 

 

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Notes:

1. Consensus for the year ended 31 March 2021 is adjusted profit before tax is £175.2 million within a range of £171.1 million - £179.8 million (source: Electrocomponents.com/investors/analyst-coverage).

2. Like-for-like revenue change is change in revenue adjusted to eliminate changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2019/20 is converted at 2020/21 average exchange rates for the period.  

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2021 for euro and US$ respectively were €1.12 and $1.31 respectively. Every 1 cent movement in the euro has a circa £1.5 million impact on annual profit. Every 1 cent movement in the US $ has a circa £0.4 million impact on annual profit.  

4. In the year ending 31 March 2022 we expect to see a positive impact of around £9 million on revenue from additional trading days compared with the year ended 31 March 2021.  

 

 

Electrocomponents plc - Conference Call Dial in Instructions

 

Date:

Tuesday 13 April

UK Time:

08.00

Chair:

David Egan

 

 

 

Participant pre-registration link:

The link can be used to pre-register in advance and also at the time of the call. 

https://www.incommglobalevents.com/registration/client/7155/electrocomponents-trading-update/

 

Participant dial in via an operator:

 

Telephone number:

+44 20 3936 2999

PIN:

621694

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRSTIFLIL
Date   Source Headline
3rd May 20224:15 pmRNSChange of Name
3rd May 20229:00 amRNSTotal Voting Rights
21st Apr 202210:00 amRNSHolding(s) in Company
12th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:45 amRNSTotal Voting Rights
31st Mar 20223:30 pmRNSCompany Secretary Change
30th Mar 20227:00 amRNSInvestor Event 2022: Our Journey to Greatness
28th Mar 202212:10 pmRNSDirectorate Change
28th Mar 202210:00 amRNSAdditional Listing
9th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSTrading Statement
1st Mar 20223:00 pmRNSTotal Voting Rights
25th Feb 20223:00 pmRNSHolding(s) in Company
15th Feb 20225:30 pmRNSHolding(s) in Company
8th Feb 20223:46 pmRNSNotice of Investor Event and Trading Update
1st Feb 20225:10 pmRNSHolding(s) in Company
1st Feb 20222:00 pmRNSTotal Voting Rights
1st Feb 20221:49 pmRNSBlock listing Interim Review
31st Jan 20225:30 pmRNSHolding(s) in Company
27th Jan 20225:50 pmRNSHolding(s) in Company
11th Jan 20223:30 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSTrading Statement
10th Jan 20224:00 pmRNSHolding(s) in Company
4th Jan 202211:04 amRNSTotal Voting Rights
17th Dec 20215:00 pmRNSHolding(s) in Company
17th Dec 20212:00 pmRNSNotice of Trading Update
10th Dec 202111:00 amRNSCompany Secretary Change
9th Dec 20219:37 amRNSHolding(s) in Company
7th Dec 202110:25 amRNSHolding(s) in Company
1st Dec 202110:21 amRNSTotal Voting Rights
11th Nov 20213:01 pmRNSHolding(s) in Company
10th Nov 20213:50 pmRNSHolding(s) in Company
4th Nov 20217:01 amRNSGlobal 2030 ESG Action Plan: For A Better World
4th Nov 20217:00 amRNSHalf-year Report
1st Nov 202110:00 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSTrading Statement
1st Oct 202110:00 amRNSTotal Voting Rights
20th Sep 20211:00 pmRNSNotice of Trading Update
13th Sep 20213:00 pmRNSDirector/PDMR Shareholding
9th Sep 202112:00 pmRNSDirector/PDMR Shareholding
1st Sep 20219:59 amRNSTotal Voting Rights
3rd Aug 202110:07 amRNSTotal Voting Rights
3rd Aug 202110:05 amRNSBlock listing Interim Review
27th Jul 20216:18 pmRNSDirector/PDMR Shareholding
26th Jul 20216:06 pmRNSHolding(s) in Company
16th Jul 20213:00 pmRNSHolding(s) in Company
15th Jul 20213:00 pmRNSResult of AGM
8th Jul 20217:00 amRNSTrading Statement
7th Jul 20214:00 pmRNSDirectorate Change
1st Jul 202111:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.